West Pharmaceutical Services Acquires Medimop Medical Projects

Medimop provides customers with technologies and systems to enhance the reconstitution, transfer and administration of pharmaceutical products in therapeutic areas including multiple sclerosis, rheumatoid arthritis, vaccines, hormones and blood derivatives for haemophilia. Medimop's products, such as MIXJECT(R), offer customers a range of solutions for drug products requiring additional handling at the point of use, the market entered directly by West through the licensing and development of its Clip'n'Ject(R) product, a proprietary, single use drug reconstitution system currently in commercial use on one drug product.